 Tags:
cancer |
|
|
|
|
|
|
« Back 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 Next » |
|
»
Women who live in gentrifying neighborhoods to receive late diagnosis of breast CANCER
Published 2008-03-13
|
| 
Women who live in Chicago's gentrifying neighborhoods are more apt to receive a late diagnosis of breast cancer than women who live in poverty-stricken neighborhoods, University of Illinois at Chicago researchers have found.
|
»
Carbon nanotubes are promising for biomedical applications and treating CANCER
Published 2008-03-13
|
| 
Carbon nanotubes-cylinders so tiny that it takes 50,000 lying side by side to equal the width of a human hair-are packed with the potential to be highly accurate vehicles for administering medicines and other therapeutic agents to patients. But a dearth of data about what happens to the tubes after they discharge their medical payloads has been a major stumbling block to progress.
|
»
Liver CANCER Survival Predicted by MicroRNA Molecules
Published 2008-03-13
|
| 
Tiny molecules that help cells regulate which proteins they make might one day help doctors predict which liver-cancer patients are likely to live longer than others, new research suggests.
|
»
Research reveals model for more accurate prediction of the risk of prostate CANCER
Published 2008-03-13
|
| 
Scientists are another step closer to understanding why some people suffer from life-threatening diseases such as cancer. New research reveals a model that may enable more accurate prediction of the risk of prostate cancer progression. By combining the Gleason score (a pathological score given to prostate cancer based on its microscopic appearance) with structured data from biomarker assessments, the researchers have developed a model for predicting the likelihood of prostate cancer virulence.
|
»
Lung CANCER Patient Response To Therapy Predicted by New Discovered Biomarkers
Published 2008-03-13
|
| 
Researchers at UCLA's Jonsson Cancer Center have discovered biomarkers that predict which patients with advanced non-small cell lung cancer will respond to a combination treatment of the anti-inflammatory drug Celebrex and the growth factor receptor blocker Tarceva.
|
»
Prostate CANCER Detected Better With experimental biomarker test
Published 2008-03-13
|
| 
An experimental biomarker test developed by researchers at the University of Michigan more accurately detects prostate cancer than any other screening method currently in use, according to a study published in the February 1 issue of Cancer Research, a journal of the American Association for Cancer Research.
|
»
Therapeutic prostate CANCER vaccines prevented development of disease In Mice
Published 2008-03-13
|
| 
Researchers at the University of Southern California have developed a prostate cancer vaccine that prevented the development of cancer in 90 percent of young mice genetically predestined to develop the disease. In the February 1 issue of Cancer Research, they suggest the same strategy might work for men with rising levels of PSA (prostate specific antigen), a potential diagnostic indicator of prostate cancer.
|
»
New study identified protein as a key player in resistance to breast CANCER therapy
Published 2008-03-13
|
| 
An innovative research approach has identified a previously unsuspected protein as a key player in the resistance to particular forms of breast cancer therapy. The study significantly advances the understanding of the molecular response to breast cancer therapies that target estrogen signaling.
|
»
New hope for breast CANCER research comes from Vet Medicine
Published 2008-03-13
|
| 
There's new hope for breast cancer research, and it's coming from a very unlikely place. Researchers at the Texas A&M University College of Veterinary Medicine & Biomedical Sciences recently published articles in the journals Molecular and Cellular Biology and Carcinogenesis indicating that a protein long suspected to play a role in Down Syndrome may also contribute to treating this devastating disease.
|
»
Age of detection is Crucial In Treating Pediatric Thyroid CANCER
Published 2008-02-26
|
| 
Efforts to treat pediatric papillary thyroid cancer are greatly improved by detecting the disease as early as possible, making the patient's age the most important factor in determining a prognosis, according to new research published in the February 2008 issue of the journal Otolaryngology -- Head and Neck Surgery.
|
»
Additional vaccine shots to reduce risk of CANCER recurrence in lung CANCER patients
Published 2008-02-26
|
| 
What if we could prevent cancer recurrence for years after surgery by giving simple recall injections every two or three years? This concept may no longer be a fantasy. In a clinical study a team headed by the international Ludwig Institute for Cancer Research (LICR) has shown that a vaccine against a protein found in cancer cells produces an immune response that can be boosted and strengthened with additional vaccine shots. Patients with resected non-small cell lung cancer (NSCLC) were treated with this investigational agent, also known as an Antigen-Specific Cancer Immunotherapeutic (ASCI), in another clinical study conducted by GlaxoSmithKline. The results showed a reduction in risk of cancer recurrence in these patients, a finding that prompted GlaxoSmithKline to initiate the largest ever clinical trial in lung cancer (MAGRIT study).
|
»
CANCER Survivors Tend to Use Vitamin And Mineral With Unknown Benefits
Published 2008-02-26
|
|
Use of vitamin and mineral supplements among cancer survivors is widespread, despite inconclusive evidence that such use is beneficial, according to a comprehensive review of scientific literature conducted by researchers at Fred Hutchinson Cancer Research Center and published Feb. 1 in the Journal of Clinical Oncology.
|
»
Liver CANCER Survival Predicted By Tiny Molecules Called microRNA
Published 2008-02-23
|
|
Tiny molecules that help cells regulate which proteins they make might one day help doctors predict which liver-cancer patients are likely to live longer than others, new research suggests.
|
»
Risk of prostate CANCER progression more accurate predicted
Published 2008-02-23
|
|
Scientists are another step closer to understanding why some people suffer from life-threatening diseases such as cancer. New research reveals a model that may enable more accurate prediction of the risk of prostate cancer progression. By combining the Gleason score (a pathological score given to prostate cancer based on its microscopic appearance) with structured data from biomarker assessments, the researchers have developed a model for predicting the likelihood of prostate cancer virulence.
|
»
Biomarkers, good predictors of response to targeted therapy in lung CANCER
Published 2008-02-23
|
|
Researchers at UCLA's Jonsson Cancer Center have discovered biomarkers that predict which patients with advanced non-small cell lung cancer will respond to a combination treatment of the anti-inflammatory drug Celebrex and the growth factor receptor blocker Tarceva.
|
»
Experimental biomarker test Detects Prostate CANCER
Published 2008-02-23
|
|
An experimental biomarker test developed by researchers at the University of Michigan more accurately detects prostate cancer than any other screening method currently in use, according to a study published in the February 1 issue of Cancer Research, a journal of the American Association for Cancer Research.
|
»
Researchers developed a prostate CANCER vaccine, effective in mice
Published 2008-02-23
|
| 
Researchers at the University of Southern California have developed a prostate cancer vaccine that prevented the development of cancer in 90 percent of young mice genetically predestined to develop the disease. In the February 1 issue of Cancer Research, they suggest the same strategy might work for men with rising levels of PSA (prostate specific antigen), a potential diagnostic indicator of prostate cancer."By early vaccination, we have basically given these mice life-long protection against a disease they were destined to have," said the study's lead investigator, W. Martin Kast, Ph.D., a professor of Molecular Microbiology & Immunology and Obstetrics & Gynecology at the Norris Comprehensive Cancer Center. "This has never been done before and, with further research, could represent a paradigm shift in the management of human prostate cancer."
|
»
A protein is key player in the resistance to certain forms of breast CANCER therapy
Published 2008-02-23
|
|
An innovative research approach has identified a previously unsuspected protein as a key player in the resistance to particular forms of breast cancer therapy. The study significantly advances the understanding of the molecular response to breast cancer therapies that target estrogen signaling.
|
»
85 percent lifetime risk of breast CANCER for women with BRCA1 gene mutation
Published 2008-02-22
|
| 
A new study may explain why women with a mutation in the BRCA1 gene face up to an 85 percent lifetime risk of breast cancer.
|
»
Major Type Of Acute Myeloid Leukemia Targeted By Kidney CANCER Drug
Published 2008-02-22
|
|
A drug used to treat kidney cancer also targets a genetic mutation active in about one third of patients with acute myeloid leukemia (AML), the most common and lethal form of adult leukemia, researchers at The University of Texas M. D. Anderson Cancer Center report in the Jan. 29 edition of the Journal of the National Cancer Institute.
|
|
|
« Back 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 Next » |
